1. Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial. (1st December 2016) Authors: Al‐Sawaf, Othman; Fischer, Kirsten; Herling, Carmen D.; Ritgen, Matthias; Böttcher, Sebastian; Bahlo, Jasmin; Elter, Thomas; Stilgenbauer, Stephan; Eichhorst, Barbara F.; Busch, Raymonde; Elberskirch, Ute; Abenhardt, Wolfgang; Kneba, Michael; Hallek, Michael; Wendtner, Clemens‐Martin Journal: European journal of haematology Issue: Volume 98:Number 3(2017:Mar.) Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL). Issue 7 (3rd July 2017) Authors: Shanafelt, Tait D.; Parikh, Sameer A.; Noseworthy, Peter A.; Goede, Valentin; Chaffee, Kari G.; Bahlo, Jasmin; Call, Timothy G.; Schwager, Susan M.; Ding, Wei; Eichhorst, Barbara; Fischer, Kirsten; Leis, Jose F.; Chanan-Khan, Asher Alban; Hallek, Michael; Slager, Susan L.; Kay, Neil E. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 7(2017) Page Start: 1630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia. (9th February 2016) Authors: Maurer, Christian; Pflug, Natali; Bahlo, Jasmin; Kluth, Sandra; Rhein, Christina; Cramer, Paula; Gross‐Ophoff, Carolin; Langerbeins, Petra; Fink, Anna‐Maria; Eichhorst, Barbara; Kreuzer, Karl‐Anton; Fischer, Norbert; Tausch, Eugen; Stilgenbauer, Stephan; Böttcher, Sebastian; Döhner, Hartmut; Kneb... Journal: European journal of haematology Issue: Volume 97:Number 3(2016:Sep.) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial. Issue 9 (September 2018) Authors: Cramer, Paula; von Tresckow, Julia; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; K... Journal: Lancet oncology Issue: Volume 19:Issue 9(2018) Page Start: 1215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia. (21st February 2018) Authors: Cramer, Paula; von Tresckow, Julia; Bahlo, Jasmin; Engelke, Anja; Langerbeins, Petra; Fink, Anna-Maria; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Böttcher, Sebastian; Eichhorst, Barbara; Hallek, Michael Journal: Future oncology Issue: Volume 14:Number 6(2018) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparison of design strategies for a three‐arm clinical trial with time‐to‐event endpoint: Power, time‐to‐analysis, and operational aspects. Issue 6 (27th June 2016) Authors: Asikanius, Elina; Rufibach, Kaspar; Bahlo, Jasmin; Bieska, Gabriele; Burger, Hans Ulrich Journal: Biometrical journal Issue: Volume 58:Issue 6(2016:Nov.) Page Start: 1295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia. Issue 5 (3rd May 2016) Authors: Müller, Dirk; Fischer, Kirsten; Kaiser, Peter; Eichhorst, Barbara; Walshe, Ronald; Reiser, Marcel; Kellermann, Lenka; Borsi, Lisa; Civello, Daniele; Mensch, Alexander; Bahlo, Jasmin; Hallek, Michael; Stock, Stephanie; Fingerle-Rowson, Günter Journal: Leukemia & lymphoma Issue: Volume 57:Issue 5(2016:May) Page Start: 1130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Economic evaluation of chronic lymphocytic leukemia from a hospital management perspective. (1st November 2016) Authors: Kron, Florian; Kutsch, Nadine; Kostenko, Anna; Dohle, Ines; Glossmann, Jan‐Peter; Müller, Dirk; Heimann, Sebastian M.; Bahlo, Jasmin; von Bergwelt‐Baildon, Michael; Eichhorst, Barbara; Wolf, Jürgen; Hallek, Michael; Zander, Thomas Journal: European journal of haematology Issue: Volume 98:Number 2(2017:Feb.) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. (2nd June 2016) Authors: Pflug, Natali; Kluth, Sandra; Vehreschild, Jörg J.; Bahlo, Jasmin; Tacke, Daniela; Biehl, Lena; Eichhorst, Barbara; Fischer, Kirsten; Cramer, Paula; Fink, Anna-Maria; von Bergwelt-Baildon, Michael; Stilgenbauer, Stephan; Hallek, Michael; Cornely, Oliver A.; Vehreschild, Maria J. G. T. Journal: Oncoimmunology Issue: Volume 5:Number 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group. Issue 4 (2nd April 2016) Authors: Goede, Valentin; Bahlo, Jasmin; Chataline, Viktoria; Eichhorst, Barbara; Dürig, Jan; Stilgenbauer, Stephan; Kolb, Gerald; Honecker, Friedemann; Wedding, Ulrich; Hallek, Michael Journal: Leukemia & lymphoma Issue: Volume 57:Issue 4(2016:Apr.) Page Start: 789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗